Show simple item record

dc.contributor.authorStelfox, Henry Thomas
dc.contributor.authorBates, David
dc.contributor.authorRedelmeier, Donald A.
dc.date.accessioned2021-08-31T16:00:53Z
dc.date.issued2003-10-08
dc.identifier.citationStelfox, Henry Thomas, Bates, David W, and Redelmeier, Donald A. "Safety of Patients Isolated for Infection Control." JAMA : The Journal of the American Medical Association 290, no. 14 (2003): 1899-905.en_US
dc.identifier.issn0098-7484en_US
dc.identifier.urihttps://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37369212*
dc.description.abstractContext: Hospital infection control policies that use patient isolation prevent nosocomial transmission of infectious diseases, but may inadvertently lead to patient neglect and errors. Objective: To examine the quality of medical care received by patients isolated for infection control. Design, setting, and patients: We identified consecutive adults who were isolated for methicillin-resistant Staphylococcus aureus colonization or infection at 2 large North American teaching hospitals: a general cohort (patients admitted with all diagnoses between January 1, 1999, and January 1, 2000; n = 78); and a disease-specific cohort (patients admitted with a diagnosis of congestive heart failure between January 1, 1999, and July 1, 2002; n = 72). Two matched controls were selected for each isolated patient (n = 156 general cohort controls and n = 144 disease-specific cohort controls). Main outcome measures: Quality-of-care measures encompassing processes, outcomes, and satisfaction. Adjustments for study cohort and patient demographic, hospital, and clinical characteristics were conducted using multivariable regression. Results: Isolated and control patients generally had similar baseline characteristics; however, isolated patients were twice as likely as control patients to experience adverse events during their hospitalization (31 vs 15 adverse events per 1000 days; P<.001). This difference in adverse events reflected preventable events (20 vs 3 adverse events per 1000 days; P<.001) as opposed to nonpreventable events (11 vs 12 adverse events per 1000 days; P =.98). Isolated patients were also more likely to formally complain to the hospital about their care than control patients (8% vs 1%; P<.001), to have their vital signs not recorded as ordered (51% vs 31%; P<.001), and more likely to have days with no physician progress note (26% vs 13%; P<.001). No differences in hospital mortality were observed for the 2 groups (17% vs 10%; P =.16). Conclusion: Compared with controls, patients isolated for infection control precautions experience more preventable adverse events, express greater dissatisfaction with their treatment, and have less documented care.en_US
dc.language.isoen_USen_US
dc.publisherAmerican Medical Association (AMA)en_US
dash.licenseMETA_ONLY
dc.titleSafety of Patients Isolated for Infection Controlen_US
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden_US
dc.relation.journalJAMAen_US
dash.depositing.authorBates, David
dc.date.available2021-08-31T16:00:53Z
dc.identifier.doi10.1001/jama.290.14.1899
dc.source.journalJAMA
dash.source.volume290;14en_US
dash.source.page1899en_US
dash.contributor.affiliatedBates, David


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record